US Patent Issued to INSERM (Institut National de la Sante et de la Recherche Medicale), Assistance Publique-Hopitaux De Paris, Sorbonne Universite on Dec. 9 for "Low dose IL-2 for treating autoimmune-related or inflammatory disorders" (French Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,232, issued on Dec. 9, was assigned to INSERM (Institut National de la Sante et de la Recherche Medicale) (Paris), Assistance Publique-Hopitaux De Paris (Paris) and Sorbonne Universite (Paris).

"Low dose IL-2 for treating autoimmune-related or inflammatory disorders" was invented by David Klatzmann (Paris), David Saadoun (Neuilly sur Seine, France), Patrice Cacoub (Le Perreux, France), Michele Rosenzwajg (Paris), Eliane Piaggio (Paris), Gilbert Bensimon (Villejuif, France) and Claude Bernard (Malakoff, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel therapies for treating autoimmune and inflammatory diseas...